Systematic Review and Meta-Analysis of Transcendental Meditation for Post-Traumatic Stress Disorder.
Medicina (Kaunas, Lithuania) – April 03, 2025
Source: PubMed
Summary
Transcendental Meditation (TM) shows significant promise in reducing PTSD symptoms, yielding a large effect size of -1.01 across 15 controlled trials involving 1,248 participants aged 20 to 54. This approach outperformed other treatments and was found to be as effective as prolonged exposure therapy, with TM producing noticeable results more quickly. Notably, 46.9% of participants were male. These findings highlight TM's potential as a viable option for stress reduction in both military and civilian populations dealing with PTSD.
Abstract
Background and Objectives. Our recent systematic review and meta-analysis of all studies on meditation as treatment for PTSD (61 studies) found a moderate effect size of Hedges's g = -0.67 for post-minus-pre change in symptom scores. Separate tests of the four meditation categories found a large effect size of g = -1.13 for the Transcendental Meditation (TM) technique that is significantly greater than for each other category. The present follow-up used a different method, calculating effects relative to internal controls, to better characterize the effects of this meditation technique. Materials and Methods. Our study followed Prisma guidelines. Major databases, research anthologies, and bibliographies were searched for studies that used TM for treating PTSD, all military and civilian populations, and all age groups. Results. The searches located 15 controlled trials on TM that met the inclusion criteria (longitudinal and reporting sufficient statistics to calculate effect sizes), 1248 subjects total, mean age 40.5 years (range 20.6 to 54.4 years), and 46.9% males (range 0% to 100%). Using the random effects model, the pooled effect across all studies of TM compared to other treatments was g = -1.01, 95% CI = -1.29 to -0.74, p < 0.000000001. One-study removed analysis found that no study reduced the pooled effect to less than -1.0. Funnel plots indicated no risk of bias. TM was non-inferior to prolonged exposure therapy, p = 0.0001, and it worked significantly faster (p = 0.04 at week six). Conclusions. TM produced clinically meaningful reductions in PTSD for civilian and military personnel, young and older adults, and for both men and women. We recommend phase-III multisite studies comparing TM with known first-line treatments for PTSD.